The importance of gene–environment interactions in human obesity

Abstract

The worldwide obesity epidemic has been mainly attributed to lifestyle changes. However, who becomes obese in an obesity-prone environment is largely determined by genetic factors. In the last 20 years, important progress has been made in the elucidation of the genetic architecture of obesity. In parallel with successful gene identifications, the number of gene-environment interaction (GEI) studies has grown rapidly. This paper reviews the growing body of evidence supporting gene-environment interactions in the field of obesity. Heritability, monogenic and polygenic obesity studies provide converging evidence that obesity-predisposing genes interact with a variety of environmental, lifestyle and treatment exposures. However, some skepticism remains regarding the validity of these studies based on several issues, which include statistical modelling, confounding, low replication rate, underpowered analyses, biological assumptions and measurement precision. What follows in this review includes (1) an introduction to the study of GEI, (2) the evidence of GEI in the field of obesity, (3) an outline of the biological mechanisms that may explain these interaction effects, (4) methodological challenges associated with GEI studies and potential solutions, and (5) future directions of GEI research. Thus far, this growing body of evidence has provided a deeper understanding of GEI influencing obesity and may have tremendous applications in the emerging field of personalized medicine and individualized lifestyle recommendations.

Amylin receptor activation in the ventral tegmental area reduces motivated ingestive behavior

“…However, the results of the free-choice diet experiments demonstrate an intriguing effect of baseline food preferences on the ability of amylin to suppress intake of particular foods. With the growing interest in individualized medicine for obesity and related comorbidities (Camilleri and Acosta, 2016; Kaul and Ali, 2016; Reddon et al, 2016), these results also underscore the importance of recognizing preexisting individual differences when identifying novel treatment strategies for obesity.…”

Physical Exercise as Therapy for Type 2 Diabetes Mellitus: From Mechanism to Orientation

“…Interaction between PA and Susceptibility Genes Interestingly, while T2DM risk variants do not interact with PA [23], obesity risk variants do [24]. Many studies demonstrated that PA can attenuate in part the impact of obesity-predisposing gene variants like FTO on BMI or body adiposity index in children, adolescents, and adults [25][26][27], which revealed the positive effects of PA on high genetic risk subgroups against obesity.…”

Natural alkaloid bouchardatine ameliorates metabolic disorders in high‐fat diet‐fed mice by stimulating the sirtuin 1/liver kinase B‐1/AMPK axis

“…Apart from these treatments that act to inhibit the intake of energy, promoting energy expenditure is another approach for the treatment of obesity and associated diseases (Lebrasseur, ; Wang et al , ; Bi et al , ; Pyrzak et al , ). For example, various interventions to increase energy expenditure such as exercise are generally beneficial for the treatment of these metabolic disorders (Jeremic et al , ; Reddon et al , ). In a search for novel pharmacological agents that act by this mechanism, we have recently identified a small molecule bouchardatine (Bou, MW: 289.3) that displays a potent efficacy in decreasing lipid accumulation in 3T3‐L1 adipocytes (Rao et al , ,b).…”